Ossotide Sodium Chloride Injection is a sterile, colorless to slightly yellow liquid designed for intravenous infusion. This product combines Ossotide, a bioactive peptide, with sodium chloride to address bone and joint-related conditions. Manufactured by Shijiazhuang Kunxiangda Technology Co., Ltd., it is a specialized medical solution tailored for patients with musculoskeletal disorders. Below is a detailed analysis of its features, applications, and technical specifications.
Product Overview
Ossotide Sodium Chloride Injection is formulated to support bone metabolism and promote healing in conditions such as proliferative bone and joint diseases, rheumatism, and rheumatoid arthritis. Its dual-component formulation includes 0.1g of Ossotide and 0.87g of sodium chloride in a 100ml glass bottle. The product is stored in a cool, shaded place and has a shelf life of 2 years when unopened.
Key Features and Advantages
Ossotide Sodium Chloride Injection offers several therapeutic benefits, including:
- Bone Metabolism Regulation: The active peptides in Ossotide stimulate osteoblast proliferation, enhancing new bone formation and calcium deposition.
- Anti-Inflammatory and Analgesic Effects: It alleviates pain and inflammation associated with rheumatoid arthritis and other inflammatory conditions.
- Fracture Healing Support: By optimizing calcium and phosphorus metabolism, it accelerates the recovery process in bone fractures.
- Convenience: The 100ml glass bottle ensures precise dosing, with a recommended administration of 50–100ml once daily for 15–30 days, as directed by a healthcare professional.
Technical Specifications
| Specification | Description |
|---|---|
| Volume | 100ml |
| Ossotide Content | 0.1g |
| Sodium Chloride Content | 0.87g |
| Formulation | Colorless to slightly yellow clear liquid |
| Storage Conditions | Sealed, in a cool and shady place |
| Shelf Life | 2 years |
| Packaging | 20 bottles per box (glass infusion bottles) |
Indications and Usage
This injection is indicated for the treatment of proliferative bone and joint diseases, rheumatism, rheumatoid arthritis, and other conditions requiring bone repair. It is administered via intravenous infusion, with a typical dosage of 50–100ml once daily. The treatment duration is generally 15–30 days, but this may vary based on individual patient needs and medical advice.
Adverse Reactions and Precautions
While generally well-tolerated, Ossotide Sodium Chloride Injection may cause allergic reactions such as fever, rash, or decreased blood pressure. It is contraindicated for individuals with severe renal insufficiency or known allergies to its components. Patients should discontinue use immediately if the solution appears turbid or if adverse effects occur. Special caution is advised for pregnant and lactating women, as it is prohibited for use during pregnancy.
Drug Interactions and Contraindications
The product should not be used concurrently with amino acid drugs or alkaline drugs, as these may interfere with its efficacy. Always consult a healthcare provider before combining with other medications to avoid potential interactions.
Company Background: Shijiazhuang Kunxiangda Technology Co., Ltd.
Shijiazhuang Kunxiangda Technology Co., Ltd. is a reputable manufacturer specializing in pharmaceutical solutions, including injectable therapies. The company adheres to stringent quality control standards to ensure the safety and efficacy of its products. Their commitment to innovation and medical research aligns with global healthcare advancements, as highlighted by NIST (National Institute of Standards and Technology) guidelines for pharmaceutical precision and measurement standards [1].
Applications in Medical Practice
Ossotide Sodium Chloride Injection is widely used in clinical settings to address musculoskeletal conditions. Its ability to regulate bone metabolism makes it a valuable tool in treating osteoporosis and post-fracture recovery. Additionally, its anti-inflammatory properties are beneficial for patients with chronic inflammatory diseases. For more details on its applications, visit the product page.
Conclusion
Ossotide Sodium Chloride Injection represents a significant advancement in the treatment of bone and joint disorders. Its unique formulation, combined with the expertise of Shijiazhuang Kunxiangda Technology Co., Ltd., ensures a reliable solution for patients and healthcare providers. As research in bone metabolism and regenerative medicine progresses, products like this will continue to play a crucial role in improving patient outcomes.
References
[1] National Institute of Standards and Technology (NIST). Retrieved from https://www.nist.gov/